ANGIODYNAMICS INC — Director's Dealing 2022

Jul 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2022-07-15

Reporting Person: Trowbridge Stephen A (EVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-15	Common Stock	M	14758	$15.95	Acquired	92935	Direct
2022-07-15	Common Stock	F	12398	$21.32	Disposed	80537	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-15	Non- Qualified Stock Option (right to buy)	$15.95	M	14758	Disposed	2022-07-22	Common Stock (14758)	Direct

Footnotes

F1: The exempt disposition of 12,398 shares of common stock of AngioDynamics, Inc. (the "Company") to the Company was made to satisfy the exercise price arising from a net (cashless) exercise of stock options that were set to expire on 7/22/2022.

F2: Options for one-fourth of the shares were each exercisable beginning 7/22/2016, 7/22/2017, 7/22/2018 and 7/22/2019, respectively.